Exponent, Inc. (NASDAQ:EXPO - Free Report) - William Blair reduced their Q1 2025 earnings estimates for shares of Exponent in a research note issued on Friday, February 7th. William Blair analyst A. Nicholas now anticipates that the business services provider will earn $0.48 per share for the quarter, down from their prior forecast of $0.56. The consensus estimate for Exponent's current full-year earnings is $2.11 per share. William Blair also issued estimates for Exponent's Q4 2025 earnings at $0.43 EPS, Q1 2026 earnings at $0.53 EPS, Q2 2026 earnings at $0.60 EPS, Q3 2026 earnings at $0.58 EPS, Q4 2026 earnings at $0.48 EPS and FY2026 earnings at $2.19 EPS.
Exponent Stock Down 0.0 %
Shares of NASDAQ EXPO traded down $0.03 during trading on Monday, hitting $90.49. 186,004 shares of the company traded hands, compared to its average volume of 227,935. The firm has a market capitalization of $4.59 billion, a P/E ratio of 42.68 and a beta of 0.71. The company has a 50-day moving average price of $91.41 and a 200-day moving average price of $100.31. Exponent has a 1 year low of $74.55 and a 1 year high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last released its earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.76%. During the same period in the prior year, the business earned $0.41 earnings per share.
Exponent Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Friday, March 7th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, March 7th. This is a positive change from Exponent's previous quarterly dividend of $0.28. This represents a $1.20 annualized dividend and a yield of 1.33%. Exponent's dividend payout ratio is currently 56.60%.
Insider Transactions at Exponent
In other news, Director Paul R. Johnston sold 1,300 shares of the firm's stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $95.03, for a total value of $123,539.00. Following the transaction, the director now owns 59,406 shares of the company's stock, valued at approximately $5,645,352.18. This trade represents a 2.14 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 2.10% of the company's stock.
Institutional Trading of Exponent
A number of institutional investors have recently added to or reduced their stakes in EXPO. Barclays PLC boosted its position in shares of Exponent by 219.0% in the third quarter. Barclays PLC now owns 96,526 shares of the business services provider's stock worth $11,127,000 after buying an additional 66,263 shares during the period. Geneva Capital Management LLC lifted its position in Exponent by 1.7% during the 3rd quarter. Geneva Capital Management LLC now owns 1,590,804 shares of the business services provider's stock worth $183,388,000 after acquiring an additional 27,339 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Exponent by 63.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider's stock worth $72,701,000 after acquiring an additional 245,086 shares during the period. Argent Capital Management LLC grew its position in Exponent by 17.3% in the fourth quarter. Argent Capital Management LLC now owns 28,323 shares of the business services provider's stock valued at $2,524,000 after acquiring an additional 4,173 shares in the last quarter. Finally, Citigroup Inc. raised its stake in shares of Exponent by 174.7% during the third quarter. Citigroup Inc. now owns 48,309 shares of the business services provider's stock valued at $5,569,000 after purchasing an additional 30,723 shares during the period. 92.37% of the stock is owned by hedge funds and other institutional investors.
About Exponent
(
Get Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Further Reading
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
